UA90253C2 - Нетаблетированные жевательные дозировочные формы для индивидуального введения - Google Patents

Нетаблетированные жевательные дозировочные формы для индивидуального введения

Info

Publication number
UA90253C2
UA90253C2 UAA200606335A UAA200606335A UA90253C2 UA 90253 C2 UA90253 C2 UA 90253C2 UA A200606335 A UAA200606335 A UA A200606335A UA A200606335 A UAA200606335 A UA A200606335A UA 90253 C2 UA90253 C2 UA 90253C2
Authority
UA
Ukraine
Prior art keywords
tabletted
composition
water
administration forms
dosed administration
Prior art date
Application number
UAA200606335A
Other languages
English (en)
Ukrainian (uk)
Inventor
Видаль Хосе Луис Фабрегас
Карбонелл Антони Массо
Гонсалес Нуриа Гарсиа
Колл Пере Гуиро
Original Assignee
Лабораториос Алмиралл, С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34610359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA90253(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Лабораториос Алмиралл, С.А. filed Critical Лабораториос Алмиралл, С.А.
Publication of UA90253C2 publication Critical patent/UA90253C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Изобретение относится к нетаблетированной жевательной дозировочной форме для индивидуального введения, которая включает композицию, которая содержит, по крайней мере, одно фармацевтически активное вещество, растворенное или диспергированное в материале матрицы, которая включает смесь не менее 0,2 масс. % желатина, по крайней мере, одного стабилизующего агента в количестве, которое превышает 1 масс. % в перерасчете на композицию, и по крайней мере, одного растворимого в воде спирта и/или воды как растворителя, причем композиция является пластичной при повышенной температуре, и характеризуется тем, чтоa) стабилизующий агент выбран из группы, которая включает (и) сложные эфиры глицерина �
UAA200606335A 2003-11-10 2004-11-09 Нетаблетированные жевательные дозировочные формы для индивидуального введения UA90253C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200302612A ES2235626B1 (es) 2003-11-10 2003-11-10 Formas de administracion masticables, no comprimidas dosificadas individualmente.

Publications (1)

Publication Number Publication Date
UA90253C2 true UA90253C2 (ru) 2010-04-26

Family

ID=34610359

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200606335A UA90253C2 (ru) 2003-11-10 2004-11-09 Нетаблетированные жевательные дозировочные формы для индивидуального введения

Country Status (25)

Country Link
US (1) US20070134318A1 (ru)
EP (1) EP1682097B1 (ru)
JP (1) JP4879021B2 (ru)
KR (1) KR20060116821A (ru)
CN (1) CN1878542A (ru)
AR (1) AR048050A1 (ru)
AT (1) ATE492270T1 (ru)
AU (1) AU2004290517B2 (ru)
BR (1) BRPI0416215A (ru)
CA (1) CA2548615A1 (ru)
CO (1) CO5690531A2 (ru)
DE (1) DE602004030706D1 (ru)
EC (1) ECSP066553A (ru)
ES (2) ES2235626B1 (ru)
IL (1) IL175285A (ru)
MY (1) MY143793A (ru)
NO (1) NO20062723L (ru)
NZ (1) NZ546375A (ru)
PE (1) PE20050488A1 (ru)
RU (1) RU2369379C2 (ru)
TW (1) TW200526266A (ru)
UA (1) UA90253C2 (ru)
UY (1) UY28586A1 (ru)
WO (2) WO2005048975A1 (ru)
ZA (1) ZA200602416B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799832B2 (en) 2003-10-23 2010-09-21 Valeant Pharmaceuticals North America Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
US7960436B2 (en) 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US8993593B2 (en) 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
NZ575652A (en) 2006-08-23 2011-08-26 Valeant Pharmaceuticals Int Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
KR20090083479A (ko) 2006-11-28 2009-08-03 밸리언트 파마슈티컬즈 인터내셔널 칼륨 채널 조절제로서의 1,4 디아미노 이환 레티가빈 유사체
US8367684B2 (en) 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
CN101686942B (zh) * 2007-06-27 2012-09-26 韩美药品株式会社 用于快速制备用于口服的崩解剂的方法及其产品
IL187159A0 (en) 2007-07-03 2009-02-11 Gur Megiddo Use of metadoxine in relief of alcohol intoxication
US7786146B2 (en) 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
WO2010013242A1 (en) 2008-07-29 2010-02-04 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate salts
EP2238976B1 (en) * 2009-04-03 2012-06-27 Hexal AG Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof
NZ597319A (en) 2009-06-25 2014-06-27 Alcobra Ltd A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
EA021368B1 (ru) * 2011-06-21 2015-06-30 Общество С Ограниченной Ответственностью "Консорциум-Пик" Препарат кардиопротекторного действия
CN105911057B (zh) * 2016-06-22 2018-10-19 扬州一洋制药有限公司 一种铝镁加混悬液的质量控制方法
TWI886158B (zh) 2019-10-10 2025-06-11 加拿大商再諾製藥公司 選擇性鉀通道調節劑之固態晶型
CA3155812A1 (en) 2019-11-08 2021-05-14 Cynthia Louise HARDEN Methods of treating depressive disorders
TW202245744A (zh) 2021-02-09 2022-12-01 加拿大商再諾製藥公司 治療失樂症之方法及用途
CN113425694A (zh) * 2021-07-02 2021-09-24 杭州蚕宝生物技术有限公司 一种石斛生物碱口腔崩解片剂及其制备方法
US12053484B2 (en) 2021-10-29 2024-08-06 Medicated Chews, Llc Simethicone chewable composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5645411A (en) * 1979-09-20 1981-04-25 Taiho Yakuhin Kogyo Kk Poultice
FR2515035A1 (fr) * 1981-10-26 1983-04-29 Rhone Poulenc Sante Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
JPH08319232A (ja) * 1995-03-22 1996-12-03 Takeda Chem Ind Ltd 粉粒状組成物
JPH0912463A (ja) * 1995-06-23 1997-01-14 Fujisawa Pharmaceut Co Ltd 口中咀嚼用製剤
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
US6171615B1 (en) * 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6060078A (en) * 1998-09-28 2000-05-09 Sae Han Pharm Co., Ltd. Chewable tablet and process for preparation thereof
US6652880B1 (en) * 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
DK1361864T3 (en) * 2001-02-14 2014-03-03 Gw Pharma Ltd FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids
US6692771B2 (en) * 2001-02-23 2004-02-17 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
RU2197094C1 (ru) * 2001-12-26 2003-01-27 Ставрулов Игорь Анатольевич Жевательная резинка

Also Published As

Publication number Publication date
WO2005048975A1 (en) 2005-06-02
CN1878542A (zh) 2006-12-13
AR048050A1 (es) 2006-03-29
ATE492270T1 (de) 2011-01-15
ES2235626A1 (es) 2005-07-01
CO5690531A2 (es) 2006-10-31
IL175285A0 (en) 2006-09-05
ES2358332T3 (es) 2011-05-09
EP1682097A2 (en) 2006-07-26
JP2007510690A (ja) 2007-04-26
JP4879021B2 (ja) 2012-02-15
ES2235626B1 (es) 2006-11-01
UY28586A1 (es) 2005-05-31
ZA200602416B (en) 2009-06-24
WO2005048974A3 (en) 2006-02-23
DE602004030706D1 (de) 2011-02-03
RU2369379C2 (ru) 2009-10-10
MY143793A (en) 2011-07-15
NO20062723L (no) 2006-06-12
TW200526266A (en) 2005-08-16
EP1682097B1 (en) 2010-12-22
ECSP066553A (es) 2006-12-20
US20070134318A1 (en) 2007-06-14
KR20060116821A (ko) 2006-11-15
RU2006120087A (ru) 2007-12-27
AU2004290517A1 (en) 2005-06-02
BRPI0416215A (pt) 2006-12-26
WO2005048974A2 (en) 2005-06-02
PE20050488A1 (es) 2005-08-24
IL175285A (en) 2011-04-28
CA2548615A1 (en) 2005-06-02
AU2004290517B2 (en) 2010-05-27
NZ546375A (en) 2009-11-27

Similar Documents

Publication Publication Date Title
WO2005048974A3 (en) Non-tabletted, chewable, individually dosed administration forms
BR0011347A (pt) Preparações e formas de administração compreendendo um composto ativo de ácido instável
ID26221A (id) Komposisi-komposisi farmasi yang dapat dijadikan gel
ATE279209T1 (de) Injizierbare pharmazeutische zusammensetzung zur systemischen verabreichung pharmakologisch aktiver wirkstoffe enthaltend mittelkettige triglyceride
RU97107927A (ru) Композиция на основе водных растворов хитозана, повышающие устойчивость растений к болезням
KR890001526A (ko) 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법
ES2185758T3 (es) Utilizacion de esteres grasos etoxilados como compuestos auto-emulsionables.
CA2082137A1 (en) Aliphatic esters as a solventless coating for pharmaceuticals
ES8101894A1 (es) Procedimiento de obtencion de una matriz polimerica de difu-sion
KR970702028A (ko) 서방성 매트릭스 펠릿제 및 이들의 제조 방법 (Sustained-Release Matrix Pellets and Method for Preparing Them)
DK1024795T3 (da) Formuleringer med reguleret frigivelse
CA2456180A1 (en) Aqueous dispersion comprising stable nanoparticles of a water-insoluble active and an excipient like middle chain triglycerides (mct)
GR3017411T3 (en) Production process of microspheres.
JP2007510690A5 (ru)
HRP20020154B1 (en) Pharmaceutical compositions for oral and topical administration
TWI255720B (en) Novel preparation and administration form comprising an acid-labile active compound and process for production thereof
BR9812835A (pt) Composição de gel para barbear não-aerossol
ATE345777T1 (de) Biologisch aktive zusammensetzung
ES2155048T3 (es) Composicion biologicamente activa.
JP2718087B2 (ja) 持効化坐剤
AU5880290A (en) Compositions
TH24457C3 (th) สารผสมของเหลวเอเควียสที่ใช้ทำความสะอาด
TH48988A3 (th) สารผสมของเหลวเอเควียสที่ใช้ทำความสะอาด
TH13079B (th) สารผสมของแท่งสบู่เจลที่เป็นเครื่องสำอางซึ่งมีเสถียรภาพที่อุณหภูมิสูงขึ้น